Published in Am J Surg Pathol on September 01, 2011
Prognostic impact of PHIP copy number in melanoma: linkage to ulceration. J Invest Dermatol (2013) 0.81
Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update. Dermatopathology (Basel) (2015) 0.75
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Immunohistochemical characteristics of melanoma. J Cutan Pathol (2008) 3.00
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res (1998) 2.44
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood (2008) 2.15
Morphological and immunophenotypic variations in malignant melanoma. Histopathology (2000) 2.02
Genetic alterations in signaling pathways in melanoma. Clin Cancer Res (2006) 2.00
Molecular diagnostics and predictors in thyroid cancer. Thyroid (2009) 1.98
An oncogenic role for ETV1 in melanoma. Cancer Res (2010) 1.94
Unusual variants of malignant melanoma. Mod Pathol (2006) 1.93
Divergent differentiation in malignant melanomas: a review. Histopathology (2007) 1.55
Malignant melanoma with a rhabdoid phenotype: histologic, immunohistochemical, and ultrastructural study of a case and review of the literature. Arch Pathol Lab Med (2004) 1.13
Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast. Breast J (2007) 1.04
Tumors composed of malignant epithelial and melanocytic populations: a case series and review of the literature. J Cutan Pathol (2008) 1.01
Synchronous primary mucosal melanoma and mucoepidermoid carcinoma of the maxillary antrum. J Laryngol Otol (1991) 0.98
Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation. Histopathology (1998) 0.97
Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases. Histopathology (2005) 0.97
Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation. N Engl J Med (2008) 0.95
Collision tumor of the stomach: gastric adenocarcinoma intermixed with gastrointestinal stromal tumor. Pathol Int (2009) 0.89
Intracranial collision metastases of prostate and esophageal carcinoma. J Neurooncol (2009) 0.86
Unusual occurrence of a melanoma with intermixed epithelial component: a true melanocarcinoma?: case report and review of epithelial differentiation in melanoma by light microscopy and immunohistochemistry. Am J Dermatopathol (2007) 0.86
Carcinosarcoma of the uterus with melanocytic differentiation. Pathol Res Pract (2007) 0.85
Collision metastasis of breast and ovarian adenocarcinoma in axillary lymph nodes: a case report and review of the literature. Pathol Oncol Res (2009) 0.83
Breast carcinoma and malignant melanoma metastasis within a single axillary lymph node. Int Semin Surg Oncol (2006) 0.81
Malignant melanoma showing smooth muscle differentiation. J Clin Pathol (1996) 0.81
Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA. Melanoma Res (2009) 0.81
Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases. Int J Surg Pathol (2007) 0.81
The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer (2009) 0.80
Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case. Am J Surg Pathol (1999) 0.78
Collision tumor of anaplastic oligodendroglioma and gangliocytoma: a case report. Brain Tumor Pathol (2009) 0.77
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res (2006) 4.29
The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med (2015) 4.24
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol (2013) 4.04
Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet (2011) 3.91
Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst (2003) 3.65
KIT as a therapeutic target in metastatic melanoma. JAMA (2011) 3.49
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A (2011) 3.10
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? Am J Surg Pathol (2012) 3.05
MC1R germline variants confer risk for BRAF-mutant melanoma. Science (2006) 2.84
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58
Improving melanoma classification by integrating genetic and morphologic features. PLoS Med (2008) 2.52
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell (2013) 2.43
Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res (2009) 2.27
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol (2006) 2.04
Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation. Pigment Cell Melanoma Res (2008) 1.98
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev (2007) 1.98
Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol (2009) 1.87
Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol (2014) 1.83
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res (2011) 1.81
Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res (2002) 1.78
Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst (2008) 1.78
A minority of foci or pan-nuclear apoptotic staining of gammaH2AX in the S phase after UV damage contain DNA double-strand breaks. Proc Natl Acad Sci U S A (2010) 1.77
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst (2013) 1.76
MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol (2008) 1.72
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med (2008) 1.69
A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet (2002) 1.69
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem (2011) 1.63
Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev (2005) 1.61
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol (2012) 1.57
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res (2013) 1.56
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res (2011) 1.47
Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings. Am J Dermatopathol (2015) 1.45
Mutation-driven drug development in melanoma. Curr Opin Oncol (2010) 1.43
The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol (2008) 1.43
Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res (2011) 1.36
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A (2002) 1.30
Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology (2007) 1.29
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med (2008) 1.25
Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol (2011) 1.23
Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res (2012) 1.23
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res (2013) 1.20
PI3-kinase subunits are infrequent somatic targets in melanoma. J Invest Dermatol (2006) 1.19
Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther (2006) 1.16
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol Cancer Res (2009) 1.14
Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet (2010) 1.11
Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases. Arch Dermatol (2008) 1.11
Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am J Dermatopathol (2010) 1.08
Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene (2003) 1.08
Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J Natl Cancer Inst (2013) 1.06
Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol (2013) 1.05
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed (2009) 1.05
Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet (2010) 1.04
Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One (2013) 1.04
Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol (2008) 1.03
GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol (2012) 1.00
Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res (2014) 0.99
Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology (2006) 0.98
KIT as a therapeutic target in melanoma. J Invest Dermatol (2010) 0.97
Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol (2004) 0.97
Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. AJR Am J Roentgenol (2009) 0.96
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis--setting the record straight. Semin Arthritis Rheum (2006) 0.95
A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred. Genes Chromosomes Cancer (2002) 0.95
Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging (2013) 0.95
Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol (2002) 0.93
Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol (2010) 0.92
HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget (2014) 0.91
SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res (2013) 0.90
Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. Am J Surg Pathol (2014) 0.90
An unconventional deep penetrating melanocytic nevus with microscopic involvement of regional lymph nodes. J Cutan Pathol (2012) 0.89
Molecular-microscopical correlation in dermatopathology. J Cutan Pathol (2011) 0.87
APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation. Gastroenterology (2007) 0.87
Atypical junctional melanocytic proliferations in benign lichenoid keratosis. Hum Pathol (2003) 0.86
High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology (2006) 0.86
PCC and COBRA-FISH a new tool to characterize primary cervical carcinomas: to assess hall-marks and stage specificity. Cancer Lett (2009) 0.85
Conceptual developments in the causes of Cockayne syndrome. Mech Ageing Dev (2013) 0.85
Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol (2015) 0.85
An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second 'primary' tumor. J Cutan Pathol (2011) 0.85
Genome-wide associations studies for melanoma and nevi. Pigment Cell Melanoma Res (2009) 0.84
Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol (2005) 0.83
Absence of PDGFRA mutations in primary melanoma. J Invest Dermatol (2007) 0.83
Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron. Radiology (2009) 0.83
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Proc Natl Acad Sci U S A (2012) 0.82
MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells. Proc Natl Acad Sci U S A (2013) 0.81
Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res (2009) 0.81
Consumption of the epidermis: a diagnostic criterion for the differential diagnosis of melanoma and Spitz nevus. Am J Surg Pathol (2004) 0.81
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Pigment Cell Melanoma Res (2014) 0.81
Beyond BRAF in melanoma. Curr Top Microbiol Immunol (2012) 0.81